Full video transcriptClick to expand
Auto-generated transcript of @dr.ahmed.elkharashy's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Just a little bit of the Red, and the Gratib, they are so good, so no matter what they're
- 0:11going to do.
- 0:14In order to build one goal, we can build the Red and the Red and the Red and the Red and
- 0:22the Red and the Red.
- 0:24I will call you in the next section on this video about your life and the missed one.
- 0:29If you feel like you are really happy about it a lot, what are you thinking?
- 0:33In the end of the video, I will say it in your opinion.
- 0:36To make you think that everything that you have in common with your life is a very tight
- 0:39scale.
- 0:39What if you live in a very tight scale, you'll have a very tight scale and a tight scale.
- 0:46When I wake up to the end, when you feel like you are a facile, and you'll probably not
- 0:50I will keep listening to this from the beginning.
- 0:55Today the pandemic has been healthy and they are healthy.
- 1:00The pandemic has been well,
- 1:02it has only been 3 years ago.
- 1:05You have to wait till.
- 1:08We have to be here.
- 1:10You have to be here.
- 1:12The pandemic is beautiful.
- 1:14We are able to go to the hospital.
- 1:15We have to be able to be healthy.
- 1:20It's not a real thing, but it's a real thing.
- 1:22It's not a real thing.
- 1:24It's a real thing, and it's a real thing.
IV NAD+ therapy: separating anti-aging hype from actual evidence
Quick answer
IV NAD therapy is administered off-label in compounding pharmacy contexts with no FDA approval for anti-aging indications, and no large-scale randomized controlled trials support its use in healthy aging populations. The available human evidence for NAD+ precursor supplementation (NR, NMN) shows modest increases in plasma NAD+ levels but inconsistent clinical outcomes across published trials. The transcript from this video is not interpretable enough to evaluate specific clinical claims directly.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For IV NAD+ therapy: separating anti-aging hype from actual evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
NAD+ Peptide Complex is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "IV NAD+ therapy: separating anti-aging hype from actual evidence" from Dr. Ahmed Elkharashy. We read the clip as a Peptide social video fact-checks claim about NAD+ Peptide Complex, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: IV NAD therapy is administered off-label in compounding pharmacy contexts with no FDA approval for anti-aging indications, and no large-scale randomized controlled trials support its use in healthy aging populations.
The reason this review is not generic is the source wording and the canonical claim label "peptides is the iv nad injection beneficial is it worth all the money." In this clip, the useful excerpt is: "Just a little bit of the Red, and the Gratib, they are so good, so no matter what they're going to do." That wording changes the review because it points to NAD+ Peptide Complex safety, access, evidence, and fit, not a one-size-fits-all protocol.
The source trail for this page is checked against The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging (2015), Effects of glycyl-histidyl-lysine-Cu on wound healing (Search), and Copper peptide and skin remodeling literature (Search), plus the creator's own wording. NAD+ Peptide Complex still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
IV NAD therapy is administered off-label in compounding pharmacy contexts with no FDA approval for anti-aging indications, and no large-scale randomized controlled trials support its use in healthy aging populations.
FormBlends verdict
NAD+ Peptide Complex safety, access, evidence, and fit
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- IV NAD therapy is administered off-label in compounding pharmacy contexts with no FDA approval for anti-aging indications, and no large-scale randomized controlled trials support its use in healthy aging populations. The available human evidence for NAD+ precursor supplementation (NR, NMN) shows modest increases in plasma NAD+ levels but inconsistent clinical outcomes across published trials. The transcript from this video is not interpretable enough to evaluate specific clinical claims directly.
- No large-scale randomized controlled trial has tested IV NAD therapy specifically for anti-aging outcomes in healthy human adults as of 2024.
- Animal studies show NAD+ precursors extend healthspan in mice (Yoshino et al., 2018, Cell Metabolism), but these findings have not been replicated in human anti-aging trials.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- No large-scale randomized controlled trial has tested IV NAD therapy specifically for anti-aging outcomes in healthy human adults as of 2024.
- Animal studies show NAD+ precursors extend healthspan in mice (Yoshino et al., 2018, Cell Metabolism), but these findings have not been replicated in human anti-aging trials.
- Oral NMN and NR supplementation raises plasma NAD+ in humans (Airhart et al., 2017, PLOS ONE), which weakens the argument that expensive IV delivery is uniquely necessary.
- IV NAD is not FDA-approved for any anti-aging indication and is administered off-label through compounding pharmacies, where sterility and concentration standards vary.
- A 2023 Nature Communications RCT (Brakedal et al.) found NR raised NAD+ in Parkinson's patients but produced no significant clinical benefit, illustrating the gap between biomarker changes and real outcomes.
- The strongest published evidence for IV NAD use is in addiction medicine for withdrawal management, not general longevity or optimization medicine.
- IV administration carries real risks including infection, phlebitis, and adverse reactions that oral supplementation does not, and those risks require disclosure when evaluating cost-benefit.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @dr.ahmed.elkharashy actually say?
Honestly? It's hard to say. The transcript from this video is largely incoherent, with fragmented sentences that don't form a coherent medical argument. Phrases like "the pandemic has been beautiful" and "you'll have a very tight scale" don't map onto any recognizable NAD claim. What we can work with is the video's caption, which promises to assess whether IV NAD injections are "beneficial" and "worth the money."
Given that framing, this fact-check will treat the video as an entry point into the actual NAD debate rather than a direct rebuttal of specific claims, because those claims simply cannot be extracted from the available transcript. That's not a technicality. A 31,000-view video on a medical topic with this level of transcript incoherence is itself a problem worth naming.
Does the science back up IV NAD therapy?
There is real biology here, but the clinical evidence for IV NAD in healthy adults is thin. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function. Declining NAD+ levels with age are well-documented. Whether IV infusion meaningfully reverses that in humans is a different question entirely.
Animal studies have shown that NAD+ precursors like NMN and NR can extend healthspan in mice (Yoshino et al., 2018, Cell Metabolism). Human trials exist but are small. A 2023 randomized controlled trial by Brakedal et al. in Nature Communications found that NR supplementation raised blood NAD+ levels in Parkinson's patients but did not produce significant clinical improvements. For IV NAD specifically, there are no large-scale RCTs in healthy aging populations. Most evidence comes from addiction medicine, where IV NAD has been used off-label to manage withdrawal symptoms. That's a very different context than anti-aging optimization.
What did the video get wrong or right?
Because the transcript is not interpretable, we cannot fairly say the creator made specific errors. What we can say is that the anti-aging framing in the caption reflects a widespread pattern of overclaiming around IV NAD therapy. Clinics charging hundreds to thousands of dollars per infusion often cite mitochondrial benefits and "cellular rejuvenation" without disclosing that these effects are largely inferred from precursor supplementation trials, not IV delivery specifically.
A few things the broader IV NAD space frequently gets wrong: oral NMN and NR raise plasma NAD+ levels in humans (Airhart et al., 2017, PLOS ONE), which undermines the premise that IV delivery is uniquely necessary. There is also no published human data showing IV NAD extends lifespan or measurably slows biological aging by validated biomarkers. The cost-to-evidence ratio here is poor. If the creator's actual video made more restrained claims, that context is lost.
What should you actually know before considering IV NAD?
IV NAD is not FDA-approved for anti-aging. It is administered off-label, typically through compounding pharmacies, and the quality and sterility of compounded IV preparations vary. That matters a lot when something goes directly into your bloodstream.
The most credible current use cases for IV NAD are in addiction medicine and acute settings, not general longevity optimization. Oral NAD+ precursors (NR and NMN) have a better-characterized safety profile and meaningful, if modest, evidence for raising systemic NAD+ levels. If you're considering IV NAD for anti-aging purposes, the honest answer from the current literature is: we don't know if it works better than oral supplementation, and the risks of IV administration are real even if rare. Anyone telling you otherwise is working ahead of the data.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Dr. Ahmed Elkharashy · TikTok creator
31.2K views on this video
Is the IV NAD injection beneficial ??? Is it worth all the money you pay? Here are the facts.#NAD #antiaging #antiagingskincare #aging #supplements
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about no large-scale randomized controlled trial has tested iv nad therapy?
No large-scale randomized controlled trial has tested IV NAD therapy specifically for anti-aging outcomes in healthy human adults as of 2024.
What does the video say about animal studies show nad+ precursors extend healthspan in mice (yoshino?
Animal studies show NAD+ precursors extend healthspan in mice (Yoshino et al., 2018, Cell Metabolism), but these findings have not been replicated in human anti-aging trials.
What does the video say about oral nmn?
Oral NMN and NR supplementation raises plasma NAD+ in humans (Airhart et al., 2017, PLOS ONE), which weakens the argument that expensive IV delivery is uniquely necessary.
What does the video say about iv nad?
IV NAD is not FDA-approved for any anti-aging indication and is administered off-label through compounding pharmacies, where sterility and concentration standards vary.
What does the video say about a 2023 nature communications rct (brakedal et al.) found nr?
A 2023 Nature Communications RCT (Brakedal et al.) found NR raised NAD+ in Parkinson's patients but produced no significant clinical benefit, illustrating the gap between biomarker changes and real outcomes.
What does the video say about the strongest published evidence for iv nad use?
The strongest published evidence for IV NAD use is in addiction medicine for withdrawal management, not general longevity or optimization medicine.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Dr. Ahmed Elkharashy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.